ICD-10 · PDGM grouping
E34 Other endocrine disorders
All 18 codes in the E34 family, with the PDGM clinical group, comorbidity subgroup and primary-position rule CMS assigns, read from the CMS grouper crosswalk v07.2.26 and the CDC FY2027 code file.
Codes in family
18
Can lead a claim
16
Cannot lead a claim
2
What CMS assigns to E34
16 of the 18 codes group to MMTA - Endocrine (12) and MMTA - Other (4); 2 are assigned no clinical group. None of the 18 is assigned a comorbidity subgroup. 16 of the 18 can lead a claim.
Every code in E34
Descriptions are CDC’s FY2027 wording; where CMS’s grouper abbreviates one, its form is shown beneath.
| Code | Description | Primary position | Clinical group | Comorbidity subgroup |
|---|---|---|---|---|
| E34.0 Carcinoid syndrome | ||||
| E34.00 | Carcinoid syndrome, unspecified | Can lead a claim | I | None |
| E34.01 | Carcinoid heart syndrome | Can lead a claim | I | None |
| E34.09 | Other carcinoid syndrome | Can lead a claim | I | None |
| E34.1 | Other hypersecretion of intestinal hormones | Can lead a claim | A | None |
| E34.2 | Ectopic hormone secretion, not elsewhere classified | Can lead a claim | A | None |
| E34.3 Short stature due to endocrine disorder | ||||
| E34.30 | Short stature due to endocrine disorder, unspecified | Can lead a claim | I | None |
| E34.31 | Constitutional short stature | Can lead a claim | I | None |
| E34.32 Genetic causes of short stature | ||||
| E34.321 | Primary insulin-like growth factor-1 (IGF-1) deficiency | Can lead a claim | I | None |
| E34.322 | Insulin-like growth factor-1 (IGF-1) resistance | Can lead a claim | I | None |
| E34.328 | Other genetic causes of short stature | Can lead a claim | I | None |
| E34.329 | Unspecified genetic causes of short stature | Can lead a claim | I | None |
| E34.39 | Other short stature due to endocrine disorder | Can lead a claim | I | None |
| E34.4 | Constitutional tall stature | Can lead a claim | A | None |
| E34.5 Androgen insensitivity syndrome | ||||
| E34.50 | Androgen insensitivity syndrome, unspecified | Cannot lead a claimPrincipal diagnosis not assigned to a clinical group | None | None |
| E34.51 | Complete androgen insensitivity syndrome | Can lead a claim | I | None |
| E34.52 | Partial androgen insensitivity syndrome | Can lead a claim | A | None |
| E34.8 | Other specified endocrine disorders | Can lead a claim | I | None |
| E34.9 | Endocrine disorder, unspecified | Cannot lead a claimPrincipal diagnosis not assigned to a clinical group | None | None |
Sources: CMS HH PPS Grouper Software v07.2.26, effective 2026-10-01, for the clinical group, comorbidity subgroup, code-first conventions and primary-position flags; CDC NCHS ICD-10-CM FY2027 code descriptions for the family title and code wording. This is the crosswalk Medicare runs a claim through. Grouping also depends on admission source, timing, the OASIS functional items and the rest of the diagnosis list.
The monthly home health regs digest
What CMS changed, what's due next, and what to do about it — one email a month, no fluff. Read the first issue